Patent ID: 11939637
Assignee: THE GENERAL HOSPITAL CORPORATION
Field: Measurement (Instruments)
Classification: CPC C  G | IPC C  G

Claim 5:
6. The method according to claim 2, wherein
(a) the genetic alteration is a mutation in CASP8, and wherein the tumor is selected from the group consisting of head and neck cancer, colorectal cancer, lung squamous cell carcinoma and uterine cancer;
(b) the genetic alteration is a mutation in PIK3CA, and wherein the tumor is stomach cancer;
(c) the genetic alteration is a mutation in B2M, and wherein the tumor is uterine cancer, breast cancer, colorectal cancer or stomach cancer;
(d) the genetic alteration is a mutation in HLA-A, B or C, and wherein the tumor is colorectal cancer, head and neck cancer, uterine cancer, stomach cancer or cervical cancer; or
(e) the genetic alteration is a mutation in CNKSR1, MET or CSNK2A1.